Urethral bulking agents for the treatment of recurrent stress urinary incontinence: A systematic review and meta-analysis.

Female urinary incontinence Mid-urethral sling failure Persistent stress urinary incontinence Recurrent stress urinary incontinence Urethral bulking agent

Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
09 2022
Historique:
received: 10 03 2022
revised: 30 04 2022
accepted: 16 05 2022
pubmed: 10 6 2022
medline: 10 8 2022
entrez: 9 6 2022
Statut: ppublish

Résumé

Recurrent stress urinary incontinence (rSUI) represents a major challenge for most clinicians as there is little evidence in the literature on the best option after sling failure. The objective of this study is to summarise the findings on the use of urethral bulking agents (UBAs) in the management of rSUI after the failure of a mid-urethral sling (MUSs). We performed a systematic review and meta-analysis, according to PRISMA 2020 guidelines, and selected eleven publications for inclusion in the analysis. We found that the overall cure and improvement rate ranged from 64% to 85% in the included studies, with a pooled value of 75%, compared with pooled failure and re-operation rates of 32% (95% CI: 22%-43%) and 25% (95% CI: 17%-34%), respectively. The I

Identifiants

pubmed: 35679770
pii: S0378-5122(22)00101-3
doi: 10.1016/j.maturitas.2022.05.007
pii:
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-37

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interest.

Auteurs

Andrea Braga (A)

Department of Obstetrics and Gynaecology, EOC - Beata Vergine Hospital, Mendrisio, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: andrea.braga@eoc.ch.

Giorgio Caccia (G)

Department of Obstetrics and Gynaecology, EOC - Beata Vergine Hospital, Mendrisio, Switzerland.

Andrea Papadia (A)

Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; Department of Obstetrics and Gynaecology, EOC - Civico Hospital, Lugano, Switzerland.

Giorgio Treglia (G)

Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; Academic Education, Research and Innovation Area, General Directorate, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Fabiana Castronovo (F)

Department of Obstetrics and Gynaecology, EOC - Beata Vergine Hospital, Mendrisio, Switzerland.

Stefano Salvatore (S)

Department of Obstetrics and Gynaecology, IRCSS San Raffaele Scientific Institute, Milan, Italy.

Marco Torella (M)

Department of Gynaecology, Obstetric and Reproductive Science, Second University of Naples, Naples, Italy.

Fabio Ghezzi (F)

Department of Obstetrics and Gynaecology, Del Ponte Hospital, University of Insubria, Varese, Italy.

Maurizio Serati (M)

Department of Obstetrics and Gynaecology, Del Ponte Hospital, University of Insubria, Varese, Italy; President of European Urogynaecological Association (EUGA), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH